Α-D-glucopyranoside, 1,3,4,6-tetra-O-sulfo-β-D-fructofuranosyl, tetrakis(hydrogen sulfate), xpotassium salt

Catalog No. :
ACRXDF400
CAS No. :
111757-57-4
Molecular Formula :
C12H21KO35S8
Molecular Weight :
1020.90

IUPAC Name:potassium ((2S,3S,4R,5R)-3,4-bis(sulfooxy)-5-((sulfooxy)methyl)-2-(((2R,3R,4S,5R,6R)-3,4,5-tris(sulfooxy)-6-((sulfooxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydrofuran-2-yl)methyl sulfate

Α-D-glucopyranoside, 1,3,4,6-tetra-O-sulfo-β-D-fructofuranosyl, tetrakis(hydrogen sulfate), xpotassium salt structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameΑ-D-glucopyranoside, 1,3,4,6-tetra-O-sulfo-β-D-fructofuranosyl, tetrakis(hydrogen sulfate), xpotassium salt
IUPAC Namepotassium ((2S,3S,4R,5R)-3,4-bis(sulfooxy)-5-((sulfooxy)methyl)-2-(((2R,3R,4S,5R,6R)-3,4,5-tris(sulfooxy)-6-((sulfooxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydrofuran-2-yl)methyl sulfate
Molecular FormulaC12H21KO35S8
Molecular Weight1020.90
SMILESO=S(=O)([O-])OC[C@@]1(O[C@H]2O[C@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)O[C@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O.[K+]
InChI KeyIXBCRTIRWNGTAU-AKSHDPDZSA-M
CAS No.111757-57-4

Synthetic Route by SureRoute

1. ACRXDF400 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRXDF400 route product structure diagram
    ACRXDF400111757-57-4
Inquiry

2. ACRXDF400 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRXDF400 route product structure diagram
    ACRXDF400111757-57-4
Inquiry

Comments (0)